UPDF AI

[Pharmacokinetic principles and drug-dosing adjustments during continuous renal replacement therapies (CRRT)].

S. Morabito,I. Guzzo,4 Authors,A. Pierucci

2006
Giornale Italiano di Nefrologia · 4 Citations

TLDR

The molecular weight cut-offs of high-flux membrane are much higher than the molecular weight of most drugs, therefore, molecular size will not be a limitation for the removal of the unbound fraction of the drugs most commonly used in the critically ill undergoing continuous renal replacement therapy (CRRT).